(Q46885878)

26 December 2017

title

Treatment of lipid disorders in patients with diabetes (English)

1 reference

26 December 2017

author

Helen M. Colhoun

series ordinal

1

1 reference

26 December 2017

author name string

David John Betteridge

series ordinal

2

1 reference

26 December 2017

publication date

1 February 2006

1 reference

26 December 2017

Current treatment options in cardiovascular medicine

published in

1 reference

26 December 2017

volume

8

1 reference

26 December 2017

issue

1

1 reference

26 December 2017

page(s)

37-45

1 reference

26 December 2017

Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11936-006-0024-8

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-006-0024-8

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-006-0024-8

Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-006-0024-8

Serum Lipids and Lipoproteins in Insulin-treated Diabetes: Demonstration of Increased High Density Lipoprotein Concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-006-0024-8

The effect of type 1 diabetes mellitus on the gender difference in coronary artery calcification

21 January 2018

1 reference

12 December 2020

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

1 reference

12 December 2020

Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT).

1 reference

12 December 2020

Risk of hospitalized stroke in men enrolled in the Honolulu Heart Program and the Framingham Study: A comparison of incidence and risk factor effects

1 reference

12 December 2020

Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM.

1 reference

12 December 2020

Standards of medical care in diabetes

1 reference

12 December 2020

Serum paraoxonase activity in patients with type 1 diabetes compared to healthy controls

1 reference

12 December 2020

Cardiovascular disease risk factors predict the development of type 2 diabetes: the insulin resistance atherosclerosis study

1 reference

12 December 2020

Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals

1 reference

12 December 2020

Type 2 diabetes as a lipid disorder.

1 reference

12 December 2020

Benefits of niacin by glycemic status in patients with healed myocardial infarction (from the Coronary Drug Project).

1 reference

12 December 2020

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

1 reference

12 December 2020

Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA).

1 reference

12 December 2020

UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine.

1 reference

12 December 2020

Is diabetes mellitus a cardiovascular disease risk equivalent for fatal stroke in women? Data from the Women's Pooling Project

1 reference

12 December 2020

Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes

1 reference

12 December 2020

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study.

1 reference

12 December 2020

Diabetes mellitus: an independent risk factor for stroke?

1 reference

12 December 2020

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

1 reference

12 December 2020

The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).

1 reference

12 December 2020

Differences in HDL-cholesterol:apoA-I + apoA-II ratio and apoE phenotype with albuminuric status in Type I diabetic patients.

1 reference

12 December 2020

Diabetic dyslipidemia

1 reference

12 December 2020

Stroke subtype and mortalitya follow-up study in 998 patients with a first cerebral infarct

1 reference

12 December 2020

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

12 December 2020

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

1 reference

12 December 2020

The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]

1 reference

12 December 2020

Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481]

1 reference

12 December 2020

Factors determining case fatality in myocardial infarction "who dies in a heart attack"?

1 reference

12 December 2020

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis

1 reference

12 December 2020

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

12 December 2020

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

12 December 2020

Relationship of phospholipid transfer protein activity to HDL and apolipoprotein B-containing lipoproteins in subjects with and without type 1 diabetes

1 reference

12 December 2020

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

1 reference

12 December 2020

The prospective pioglitazone clinical trial in macrovascular events (PROactive): can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients

1 reference

12 December 2020

Diabetic dyslipidaemia: from basic research to clinical practice.

1 reference

12 December 2020

10.1007/S11936-006-0024-8

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017